We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Expensify
EXFY
$237M
| $422K | ﹤0.01% |
162,984
-2,700
| -2% | -$6.9K |
|
1377
Dana Inc
DAN
$3.28B
| $421K | ﹤0.01% |
24,560
-4,894
| -17% | -$73.1K |
|
1378
Allegro MicroSystems
ALGM
$6.84B
| $417K | ﹤0.01% |
12,204
+4,712
| +63% | +$117K |
|
1379
Associated Banc-Corp
ASB
$5.86B
| $417K | ﹤0.01% |
17,077
+3,315
| +24% | +$74.7K |
|
1380
Vail Resorts
MTN
$5.14B
| $414K | ﹤0.01% |
2,634
-94
| -3% | -$14K |
|
1381
Silgan Holdings
SLGN
$4.46B
| $411K | ﹤0.01% |
7,591
-2,699
| -26% | -$143K |
|
1382
Brighthouse Financial
BHF
$3.13B
| $409K | ﹤0.01% |
7,604
-6,535
| -46% | -$367K |
|
1383
Hyatt Hotels
H
$16.3B
| $407K | ﹤0.01% |
2,918
-62
| -2% | -$7.74K |
|
1384
Century Aluminum
CENX
$4.52B
| $405K | ﹤0.01% |
22,454
-42,944
| -66% | -$729K |
|
1385
Provident Financial
PROV
$115M
| $404K | ﹤0.01% |
26,033
+631
| +2% | +$9.48K |
|
1386
Spire
SR
$4.93B
| $402K | ﹤0.01% |
5,509
-16
| -0.3% | -$1.2K |
|
1387
Sonoco
SON
$5.6B
| $401K | ﹤0.01% |
9,207
-97
| -1% | -$4.34K |
|
1388
Strategy Inc
MSTR
$52.5B
| $396K | ﹤0.01% |
+979
| New | +$357K |
|
1389
AST SpaceMobile
ASTS
$17.8B
| $394K | ﹤0.01% |
+8,427
| New | +$244K |
|
1390
Macy's
M
$5.94B
| $392K | ﹤0.01% |
33,615
-10,264
| -23% | -$119K |
|
1391
AppFolio
APPF
$8.23B
| $388K | ﹤0.01% |
1,685
-10,051
| -86% | -$2.19M |
|
1392
Euronet Worldwide
EEFT
$2.57B
| $385K | ﹤0.01% |
3,795
+1,095
| +41% | +$113K |
|
1393
Sierra Bancorp
BSRR
$522M
| $381K | ﹤0.01% |
12,826
+665
| +5% | +$18.1K |
|
1394
CSX Corp
CSX
$95.1B
| $380K | ﹤0.01% |
11,635
-571
| -5% | -$17.2K |
|
1395
GATX Corp
GATX
$6.28B
| $379K | ﹤0.01% |
2,471
-53
| -2% | -$7.94K |
|
|
CAI
1396
Caris Life Sciences
CAI
$7.49B
| $379K | ﹤0.01% |
+14,200
| New | +$383K |
|
1397
Harley-Davidson
HOG
$2.88B
| $379K | ﹤0.01% |
16,076
+3,967
| +33% | +$94.2K |
|
1398
Similarweb
SMWB
$800M
| $376K | ﹤0.01% |
48,000
+16,500
| +52% | +$124K |
|
1399
Warner Music
WMG
$14.7B
| $371K | ﹤0.01% |
13,619
-109
| -0.8% | -$3.04K |
|
|
YB
1400
Yuanbao Inc
YB
$641M
| $370K | ﹤0.01% |
+17,600
| New | +$293K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.